Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 4366

1.

Are Risk Factors for Menstrual Dysfunction Cumulative?

Myburgh KH, Watkin VA, Noakes TD.

Phys Sportsmed. 1992 Apr;20(4):114-25. doi: 10.1080/00913847.1992.11710277.

PMID:
27424644
2.

Transdermal progesterone: effects on menopausal symptoms and on thrombotic, anticoagulant, and inflammatory factors in postmenopausal women.

Stephenson K Md Faafp, Neuenschwander PF Phd Faha, Kurdowska AK Phd, Pinson B Ms Md, Price C Msn.

Int J Pharm Compd. 2008 Jul-Aug;12(4):295-304.

PMID:
23969765
3.

Primary Care Management of Abnormal Uterine Bleeding [Internet].

Hartmann KE, Jerome RN, Lindegren ML, Potter SA, Shields TC, Surawicz TS, Andrews JC.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Mar.

4.

Thrombotic risks of oral contraceptives.

Rott H.

Curr Opin Obstet Gynecol. 2012 Aug;24(4):235-40. doi: 10.1097/GCO.0b013e328355871d. Review.

PMID:
22729096
5.

Thrombotic stroke and myocardial infarction with hormonal contraception.

Lidegaard Ø, Løkkegaard E, Jensen A, Skovlund CW, Keiding N.

N Engl J Med. 2012 Jun 14;366(24):2257-66. doi: 10.1056/NEJMoa1111840.

6.

Bioequivalence and x-ray visibility of a radiopaque etonogestrel implant versus a non-radiopaque implant: a 3-year, randomized, double-blind study.

Schnabel P, Merki-Feld GS, Malvy A, Duijkers I, Mommers E, van den Heuvel MW.

Clin Drug Investig. 2012 Jun 1;32(6):413-22. doi: 10.2165/11631930-000000000-00000.

PMID:
22540269
7.

Efficacy, safety, and tolerability of a monophasic oral contraceptive containing nomegestrol acetate and 17β-estradiol: a randomized controlled trial.

Westhoff C, Kaunitz AM, Korver T, Sommer W, Bahamondes L, Darney P, Verhoeven C.

Obstet Gynecol. 2012 May;119(5):989-99. doi: 10.1097/AOG.0b013e318250c3a0.

PMID:
22525910
8.
9.

Long-term tolerability of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study.

Klipping C, Duijkers I, Fortier MP, Marr J, Trummer D, Elliesen J.

J Fam Plann Reprod Health Care. 2012 Apr;38(2):84-93. doi: 10.1136/jfprhc-2011-100214.

10.

Contraceptive efficacy and tolerability of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study.

Klipping C, Duijkers I, Fortier MP, Marr J, Trummer D, Elliesen J.

J Fam Plann Reprod Health Care. 2012 Apr;38(2):73-83. doi: 10.1136/jfprhc-2011-100213.

11.

Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20 to 44 years of age.

Li CI, Beaber EF, Tang MT, Porter PL, Daling JR, Malone KE.

Cancer Res. 2012 Apr 15;72(8):2028-35. doi: 10.1158/0008-5472.CAN-11-4064. Epub 2012 Feb 27.

12.

Augmenting clozapine with sertindole: a double-blind, randomized, placebo-controlled study.

Nielsen J, Emborg C, Gydesen S, Dybbro J, Aagaard J, Haderup K, Glyngdal P, Fabricius S, Thode D, Lublin H, Andersen T, Damkier P, Taylor D.

J Clin Psychopharmacol. 2012 Apr;32(2):173-8. doi: 10.1097/JCP.0b013e318248dfb8.

PMID:
22367659
13.

Cost burden and treatment patterns associated with management of heavy menstrual bleeding.

Jensen JT, Lefebvre P, Laliberté F, Sarda SP, Law A, Pocoski J, Duh MS.

J Womens Health (Larchmt). 2012 May;21(5):539-47. doi: 10.1089/jwh.2011.3147. Epub 2012 Feb 23.

PMID:
22360696
14.

A comparative trial of copper T 380 and Cu 375 IUCD.

Khan SA, Ul Amin Z, Fouzia, Jadoon S.

J Ayub Med Coll Abbottabad. 2010 Jul-Sep;22(3):185-7.

PMID:
22338452
15.

Cabergoline for preventing ovarian hyperstimulation syndrome.

Tang H, Hunter T, Hu Y, Zhai SD, Sheng X, Hart RJ.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD008605. doi: 10.1002/14651858.CD008605.pub2. Review.

PMID:
22336848
16.

Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians.

Qaseem A, Humphrey LL, Sweet DE, Starkey M, Shekelle P; Clinical Guidelines Committee of the American College of Physicians.

Ann Intern Med. 2012 Feb 7;156(3):218-31. doi: 10.7326/0003-4819-156-3-201202070-00011. Erratum in: Ann Intern Med. 2012 May 15;156(10):756. Ann Intern Med. 2012 Jul 17;157(2):152.

PMID:
22312141
17.

Ulipristal acetate versus leuprolide acetate for uterine fibroids.

Donnez J, Tomaszewski J, Vázquez F, Bouchard P, Lemieszczuk B, Baró F, Nouri K, Selvaggi L, Sodowski K, Bestel E, Terrill P, Osterloh I, Loumaye E; PEARL II Study Group.

N Engl J Med. 2012 Feb 2;366(5):421-32. doi: 10.1056/NEJMoa1103180.

18.

Ulipristal acetate versus placebo for fibroid treatment before surgery.

Donnez J, Tatarchuk TF, Bouchard P, Puscasiu L, Zakharenko NF, Ivanova T, Ugocsai G, Mara M, Jilla MP, Bestel E, Terrill P, Osterloh I, Loumaye E; PEARL I Study Group.

N Engl J Med. 2012 Feb 2;366(5):409-20. doi: 10.1056/NEJMoa1103182.

19.

Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis.

Bodmer M, Becker C, Meier C, Jick SS, Meier CR.

Am J Gastroenterol. 2012 Apr;107(4):620-6. doi: 10.1038/ajg.2011.483. Epub 2012 Jan 31.

PMID:
22290402
20.

Oral contraceptives and venous thromboembolism: a systematic review and meta-analysis.

Manzoli L, De Vito C, Marzuillo C, Boccia A, Villari P.

Drug Saf. 2012 Mar 1;35(3):191-205. doi: 10.2165/11598050-000000000-00000. Review.

PMID:
22283630
Items per page

Supplemental Content

Write to the Help Desk